低分子肝素在血液透析中的应用  

Application of low molecular weight heparin in hemodialysis

作　　者：霍苗苗[1] 余毅[1] 

机构地区：[1]南京军区福州总医院血液净化科,福州350025

出　　处：《世界临床药物》2014年第2期88-91,共4页World Clinical Drug

摘　　要：低分子肝素(LMWH)与普通肝素相比具有抗凝作用强、生物利用度高、血浆半衰期长等优点,且极少引起血脂代谢紊乱及骨代谢异常,在临床血液透析治疗中应用较广。本文综述LMWH在血液透析中的应用现状。Compared with unfractionated heparin, Low molecular weight heparin （LMWH） has significant anti-coagulation activity, high bioavailability and longer half-life. In addition, the effect on serum lipids and bone metabolism is favourable. LMWH is found to have an established role in hemodialysis. This review describes the application of LMWH in hemodialysis.

关 键 词：低分子肝素(LMWH) 血液透析 应用 

分 类 号：R459.5[医药卫生—治疗学] R973.2[医药卫生—临床医学]